Copy of Congressional House Bill 6638, To amend chapter V of the Federal Food, Drug, and Cosmetic Act to enhance the requirements for pharmacies that compound drug products, also known as “Supporting Access to Formulated and Effective Compounded Drugs Act of 2012” or the “S.A.F.E. Compounded Drugs Act of 2012”.

To review this bill click here

Facing Congressional Probe, Compounding Group Denies Helping Pharmacists Sidestep FDA

A bipartisan congressional inquiry into allegations an international compounding group helped pharmacies sidestep FDA oversight, a probe spurred by a recent New York Times article, prompted a vociferous denial Friday (Dec. 7) by the trade group, which said it would hand over internal documents that refute the article's conclusion.

Source found here.  Subscription required.

Industry, GPOs Urge Dems Not To Confuse Compounding, Drug Shortage Issues

Two drug manufacturers and a trade group representing group purchasing organizations are pushing back against a recent request by House Democrats for Congress' investigative arm to probe the relationship between drug compounding, drug shortages and GPOs.

Source found here.  Subscription required.

Committee Leaders Request Documents from Drug Compounding Industry Association | Congressman Henry Waxman

Committee Leaders Request Documents from Drug Compounding Industry Association | Congressman Henry Waxman